Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease ...Middle East

TAIPEI, Oct. 30, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company will be presenting at the American Heart Association (AHA) 2023 Annual Meeting taking place in Philadelphia, PA, from November 11-13, 2023. The presentation will focus...

Hence then, the article about foresee pharmaceuticals to present at the american heart association annual meeting focusing on its aldh2 activator fp 045 in pulmonary hypertension associated with interstitial lung disease was published today ( Monday 30/10/2023 - 10:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease )

Also on site :

• UN urges probe into deaths in Pakistani-administered Kashmir unrest
• I Tried 14 Fast-Food Fries to Find the Best—and the Winner Won by a Landslide
• San Sebastián: New Titles From J.A.Bayona, ’The Beloved’ Scribe Isabel Peña and Fernando Trueba; Mikel Gurrea, Berto Romero and Roberto Bueso Set for Competition